Can you provide the average price target for ADIENT PLC stock?
20 analysts have analysed ADNT and the average price target is 30.8 USD. This implies a price increase of 41.33% is expected in the next year compared to the current price of 21.79.
NYSE:ADNT • IE00BD845X29
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADIENT PLC (ADNT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-15 | Citigroup | Upgrade | Neutral -> Buy |
| 2026-04-14 | Stifel | Maintains | Buy -> Buy |
| 2026-03-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-30 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-09 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-05 | UBS | Maintains | Buy -> Buy |
| 2026-02-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-23 | Stifel | Maintains | Buy -> Buy |
| 2026-01-23 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-14 | UBS | Upgrade | Neutral -> Buy |
| 2026-01-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-08 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2025-11-12 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | Stifel | Maintains | Buy -> Buy |
| 2025-11-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-20 | Stifel | Maintains | Buy -> Buy |
| 2025-10-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-10 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-25 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 15.395B 9.02% | 14.688B -4.59% | 14.535B -1.04% | 14.929B 2.71% | 15.281B 2.36% | 15.666B 2.52% | 15.827B 1.03% | 15.985B 1.00% | |
| EBITDA YoY % growth | 819M 40.96% | 768M -6.23% | 814M 5.99% | 896.21M 10.10% | 974.11M 8.69% | 1.057B 8.51% | 1.272B 20.34% | 1.302B 2.36% | |
| EBIT YoY % growth | 479M 107.36% | 436M -8.98% | 489M 12.16% | 540.35M 10.50% | 626.45M 15.93% | 713.91M 13.96% | 901.68M 26.30% | 927.18M 2.83% | |
| Operating Margin | 3.11% | 2.97% | 3.36% | 3.62% | 4.10% | 4.56% | 5.70% | 5.80% | |
| EPS YoY % growth | 2.15 2,050.00% | 1.85 -13.95% | 1.93 4.32% | 2.11 9.47% | 3.23 52.68% | 4.49 39.34% | 7.04 56.58% | 7.66 8.84% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.44 -36.74% | 0.64 41.87% | 0.68 31.53% | 0.61 74.76% | 0.76 74.10% | 1.01 57.77% | 0.95 38.69% | 0.86 40.08% | 0.82 7.38% | 1.12 11.39% | 1.24 31.18% |
| Revenue Q2Q % growth | 3.704B 2.58% | 3.796B 1.47% | 3.726B 1.03% | 3.732B 2.41% | 3.82B 3.13% | 3.893B 2.56% | 3.744B 0.48% | 3.934B 5.41% | 3.967B 3.85% | 3.982B 2.29% | 3.905B 4.30% |
| EBITDA Q2Q % growth | 211.66M -25.99% | 233.28M -34.10% | 240.63M -47.92% | 215.83M 15.42% | 225.02M 6.31% | 260.13M 11.51% | 248.59M 3.31% | 246.84M 14.37% | 241.74M 7.43% | 273.36M 5.09% | 277.44M 11.61% |
| EBIT Q2Q % growth | 126.5M -0.39% | 145.26M 29.70% | 151.3M 10.44% | 123.89M 15.79% | 140.9M 11.38% | 175.04M 20.50% | 153.66M 1.56% | N/A | N/A | N/A | N/A |
All data in USD
20 analysts have analysed ADNT and the average price target is 30.8 USD. This implies a price increase of 41.33% is expected in the next year compared to the current price of 21.79.
ADIENT PLC (ADNT) will report earnings on 2026-05-06, before the market open.
The consensus EPS estimate for the next earnings of ADIENT PLC (ADNT) is 0.44 USD and the consensus revenue estimate is 3.70B USD.
The consensus rating for ADIENT PLC (ADNT) is 74 / 100 . This indicates that analysts generally have a positive outlook on the stock.